İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

ELİF ŞEN

PROFESÖR

ANKARA ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Göğüs Hastalıkları

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 65
  • Proje 0
  • Kitap 0
  • Bildiri 37
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 7 Q2 9 Q3 18 Q4 3
WoS (JCR) Q1 3 Q2 8 Q3 9 Q4 17
TR Index 16 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 2
Ort. yüzdelik 66.7%
Üst %1 payı 0.0%
Üst %10 payı 5.4%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 65 yayın

Scopus (SJR)
Q1 7 Q2 9 Q3 18 Q4 3
WoS (JCR)
Q1 3 Q2 8 Q3 9 Q4 17
TR Index
16 makale

Makale listesi

  1. 2025 Impact of COVID-19 and lockdown on outcomes of COPD patients in Turkey: lessons for the future BMC PULMONARY MEDICINE DOI 10.1186/s12890-025-03883-8 YÖKSİS SJR Q2 JCR Q2 OpenAlex 71.6%
  2. 2025 Thoracic metabolic tumor volume predicts survival in advanced lung adenocarcinoma: a PET/computed tomography-based cohort study NUCLEAR MEDICINE COMMUNICATIONS DOI 10.1097/MNM.0000000000001983 YÖKSİS SJR Q3 JCR Q3 OpenAlex 11.0%
  3. 2025 Validation Study of Rome Criteria for Assessing COPD Exacerbation Severity and Predicting Clinical Outcomes: Turkish Thoracic Society COPD Assembly INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE DOI 10.2147/COPD.S554744 YÖKSİS SJR Q1 JCR Q1 OpenAlex 88.8%
  4. 2025 Challenging diagnosis of central nervous system tuberculosis with joint involvement Tüberküloz ve Toraks DOI 10.5578/tt.2025041096 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 63.4%
  5. 2025 Patients with chronic obstructive pulmonary disease and the use of complementary and alternative medicine: The role of health literacy in Türkiye CHRONIC RESPIRATORY DISEASE DOI 10.1177/14799731251382230 YÖKSİS SJR Q2 JCR Q2 OpenAlex 30.3%
  6. 2024 Importance of mediastinal granulomatous/sarcoid-like lymphadenopathy in extrathoracic malignancies. Diagnostic cytopathology DOI 10.1002/dc.25337 YÖKSİS OpenAlex 68.2%
  7. 2024 Readmission rates within the first 30 and 90 days after severe COPD exacerbations (RACE study). Medicine DOI 10.1097/MD.0000000000040483 YÖKSİS SJR Q3 JCR Q2 OpenAlex 74.8%
  8. 2024 Risk factors for prolonged hospitalization as a marker for difficult-to-manage exacerbations of chronic obstructive lung disease (COPD): the DiMECO Study. BMC pulmonary medicine DOI 10.1186/s12890-024-03399-7 YÖKSİS OpenAlex 75.0%
  9. 2024 Asthma-chronic obstructive pulmonary disease overlap: Results from a national-multicenter study. Tuberkuloz ve toraks DOI 10.5578/tt.202401886 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 64.6%
  10. 2024 Reliability of comorbidity indices as predictive indicators for frequent severe chronic obstructive pulmonary disease exacerbations. Tuberkuloz ve toraks DOI 10.5578/tt.202401833 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 71.7%
  11. 2024 Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS. Pragmatic and observational research DOI 10.2147/POR.S438031 YÖKSİS JCR Q1 OpenAlex 70.5%
  12. 2022 The CO-MIND Study: Chronic Obstructive Pulmonary Disease Management in Daily Practice and Its Implications for Improved Outcomes According to GOLD 2019 Perspective International Journal of COPD DOI 10.2147/COPD.S372439 YÖKSİS SJR Q1 JCR Q2 OpenAlex 54.5%
  13. 2022 Is endobronchial ultrasound - transbronchial needle aspiration (EBUS-TBNA) reliable and safe procedure in geriatric patients? Aging Clinical and Experimental Research DOI 10.1007/s40520-021-02012-9 YÖKSİS SJR Q2 JCR Q2 OpenAlex 57.2%
  14. 2022 Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone International Journal of COPD DOI 10.2147/COPD.S342357 YÖKSİS SJR Q1 JCR Q2 OpenAlex 74.1%
  15. 2022 Prognostic value of metabolic parameters on baseline 18F-FDGPET/CT in small cell lung cancer Quarterly Journal of Nuclear Medicine and Molecular Imaging DOI 10.23736/S1824-4785.19.03169-8 YÖKSİS SJR Q3 JCR Q4 OpenAlex 87.6%
  16. 2022 Evaluation of lung cancer biomarkers profile for the decision of targeted therapy in EBUS-TBNA cytological samples Scottish Medical Journal DOI 10.1177/00369330221078995 YÖKSİS SJR Q3 JCR Q3 OpenAlex 63.3%
  17. 2022 The effect of health-related quality of life and physical activity on time to first exacerbation in chronic obstructive pulmonary disease patients Tüberküloz ve Toraks DOI 10.5578/tt.20229606 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 49.3%
  18. 2021 Is EBUS-TBNA reliable and safe procedure in geriatric patients? Aging Clinical and Experimental Research DOI 10.1007/s40520-021-02012-9 YÖKSİS SJR Q2 JCR Q2 OpenAlex 57.2%
  19. 2021 2021 Guideline for the Management of COPD Exacerbations: Emergency Medicine Association of Turkey (EMAT) / Turkish Thoracic Society (TTS) Clinical Practice Guideline Task Force Turkish Journal of Emergency Medicine DOI 10.4103/2452-2473.329630 YÖKSİS TR Index SJR Q1 JCR Q3 OpenAlex 89.3%
  20. 2021 Unmet need in the management of chronic obstructive pulmonary disease in the Middle East and Africa region: An expert panel consensus Respiratory Medicine DOI 10.1016/j.rmed.2021.106641 YÖKSİS SJR Q1 JCR Q2 OpenAlex 73.0%

Akademisyenlere dön